- Filed
- Mar 9, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2026 · Mar 5, 2026 | 1.81M sh |
| Stock Issued | Q3 2026 · Dec 31, 2025 | 51.2K sh |
| Shares Diluted | Q3 2026 · Dec 31, 2025 | 1.93M sh |
| Shares Diluted | Q3 2026 · Dec 31, 2025 | 2.48M sh |
| Shares Diluted | Q3 2026 · Dec 31, 2024 | 5.4M sh |
| Shares Diluted | Q3 2026 · Dec 31, 2024 | 5.4M sh |
| Operating Cash Flow | Q3 2026 · Dec 31, 2025 | −$3.07M |
| Operating Cash Flow | Q3 2026 · Dec 31, 2024 | −$917.51K |
| Stockholders Equity | Q3 2026 · Dec 31, 2025 | −$2.39M |
| Stockholders Equity | Q3 2026 · Sep 30, 2025 | −$4.7M |
| Stockholders Equity | Q3 2026 · Jun 30, 2025 | −$3.97M |
| Stockholders Equity | Q3 2026 · Mar 31, 2025 | −$4.95M |
| Stockholders Equity | Q3 2026 · Dec 31, 2024 | −$3.32M |
| Stockholders Equity restated | Q3 2026 · Sep 30, 2024 | −$2.47M |
| Stockholders Equity restated | Q3 2026 · Jun 30, 2024 | −$1.75M |
| Stockholders Equity restated | Q3 2026 · Mar 31, 2024 | −$1.79M |
| Current Liabilities | Q3 2026 · Dec 31, 2025 | $6.82M |
| Current Liabilities | Q3 2026 · Mar 31, 2025 | $5.04M |
| Total Liabilities | Q3 2026 · Dec 31, 2025 | $6.82M |
| Total Liabilities | Q3 2026 · Mar 31, 2025 | $5.04M |
| Current Assets | Q3 2026 · Dec 31, 2025 | $2.3M |
| Current Assets | Q3 2026 · Mar 31, 2025 | $89.09K |
| Total Assets | Q3 2026 · Dec 31, 2025 | $4.43M |
| Total Assets | Q3 2026 · Mar 31, 2025 | $89.09K |
| Eps Diluted | Q3 2026 · Dec 31, 2025 | $1.14 |
| Eps Diluted | Q3 2026 · Dec 31, 2025 | −$1.50 |
| Eps Diluted | Q3 2026 · Dec 31, 2024 | −$0.16 |
| Eps Diluted | Q3 2026 · Dec 31, 2024 | −$0.33 |
| Eps Basic | Q3 2026 · Dec 31, 2025 | $1.14 |
| Eps Basic | Q3 2026 · Dec 31, 2025 | −$1.50 |
| Eps Basic | Q3 2026 · Dec 31, 2024 | −$0.16 |
| Eps Basic | Q3 2026 · Dec 31, 2024 | −$0.33 |
| Sga Expense | Q3 2026 · Dec 31, 2025 | $154.82K |
| Sga Expense | Q3 2026 · Dec 31, 2025 | $489.95K |
| Sga Expense | Q3 2026 · Dec 31, 2024 | $49.7K |
| Sga Expense | Q3 2026 · Dec 31, 2024 | $95.47K |
| Rd Expense | Q3 2026 · Dec 31, 2025 | $153.79K |
| Rd Expense | Q3 2026 · Dec 31, 2025 | $821.13K |
| Rd Expense | Q3 2026 · Dec 31, 2024 | $134.58K |
| Rd Expense | Q3 2026 · Dec 31, 2024 | $170.68K |
| Net Income | Q3 2026 · Dec 31, 2025 | $2.21M |
| Net Income | Q3 2026 · Dec 31, 2025 | −$3.72M |
| Net Income | Q3 2026 · Sep 30, 2025 | −$869.5K |
| Net Income | Q3 2026 · Jun 30, 2025 | −$5.06M |
| Net Income | Q3 2026 · Dec 31, 2024 | −$850.29K |
| Net Income | Q3 2026 · Dec 31, 2024 | −$1.76M |
| Net Income restated | Q3 2026 · Sep 30, 2024 | −$582.39K |
| Net Income restated | Q3 2026 · Jun 30, 2024 | −$324.36K |
| Operating Income | Q3 2026 · Dec 31, 2025 | −$925.1K |
| Operating Income | Q3 2026 · Dec 31, 2025 | −$4.38M |
| Operating Income | Q3 2026 · Dec 31, 2024 | −$401.4K |
| Operating Income | Q3 2026 · Dec 31, 2024 | −$1.08M |
| Revenue | Q3 2026 · Dec 31, 2025 | $0 |